Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice
- PMID: 24453945
- PMCID: PMC3891615
- DOI: 10.1371/journal.pmed.1001584
Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice
Abstract
Rafael Dal-Ré and colleagues discuss how incidental findings are likely to be viewed as potential benefits of research participation in genomics trials, and investigators should implement mechanisms to ensure provision of timely and appropriate care. Ensuring provision of such interventions in countries lacking a universal public health care system may prove challenging.
Please see later in the article for the Editors' Summary
Conflict of interest statement
The authors have declared that no competing interests exist. The opinions expressed in this article are those of the authors and may not reflect the opinions of the organizations that they work for.
References
-
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979) Belmont report: ethical principles and guidelines for the protection of human subjects of research. Fed Regist 44: 23192–23197.
-
- Dresser R (2011) The role of patient advocates and public representatives in research. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, et al. The Oxford textbook of clinical research ethics. Oxford: Oxford University Press pp. 231–241.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
